NCT02913131 Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT02911922 Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer Status TERMINATED Phase NA
NCT02911467 Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT02911350 Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer Status COMPLETED Phase PHASE1
NCT02905318 Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02903368 Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy Status COMPLETED Phase PHASE2
NCT02903160 Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE2
NCT02899312 PSMA PET/CT for Assessment of Recurrent Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02895854 LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients Status UNKNOWN Phase NA
NCT02895230 Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study Status COMPLETED Phase N/A
NCT02887976 Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 Status COMPLETED Phase PHASE3
NCT02886546 Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy Status TERMINATED Phase NA
NCT02883166 Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake Status COMPLETED Phase PHASE1
NCT02882958 Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate Status COMPLETED Phase N/A
NCT02882178 Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy Status COMPLETED Phase N/A
NCT02876237 Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer Status COMPLETED Phase NA